​

What Is Cagrilintide?

 

Cagrilintide is a medication currently being studied for weight management and metabolic health. It is a long-acting amylin analogue, designed to mimic the natural hormone amylin, which plays a role in appetite control, stomach emptying, and feelings of fullness after eating.

​

How Does Cagrilintide Work?

 

Cagrilintide works differently from GLP-1–based medications. Instead of targeting incretin hormones, it activates amylin receptors, which help regulate appetite and energy balance:

 

• Amylin receptors — Help increase satiety, reduce hunger signals, and slow gastric emptying.

• Brain appetite pathways — Influence areas involved in food intake and portion control.

• Energy regulation — May support reduced calorie intake by enhancing fullness.

 

By mimicking natural amylin, researchers aim to create meaningful weight-loss effects, and studies are also exploring its use alongside other metabolic therapies.

 

Potential Benefits?

​​

• Significant body-weight reduction in some clinical trial participants

• Reduced appetite and improved satiety

• Lower calorie intake

• Support for long-term weight management strategies

 

Side Effects and Safety Considerations?

 

As with many appetite-regulating peptide medications, reported side effects may include:

 

• Nausea or digestive discomfort

• Vomiting or diarrhoea

• Reduced appetite

• Fatigue or mild gastrointestinal symptoms in some individuals

 

Recommended Dosing Schedule?

 

Estimated Half-Life is Approximately 7 days.

 

Why it matters:
• Supports once-weekly dosing in studies
• Helps maintain stable drug levels over time
• Effects may last several days after an injection

 

Steady state is the point where the amount of medication entering the body equals the amount being cleared.

Steady state is usually reached after about 4–5 half-lives of a medication.

Approximately 4 weeks after starting consistent weekly dosing.

 

Cagrilintide is typically introduced using a gradual dose-escalation approach to help improve tolerability, It is recommended to start on a dose of 0.25mg.

 

Each time the dose is increased, it is important to allow the body time to reach steady state again before making further adjustments. This gradual approach helps maintain stable drug levels and may reduce the likelihood of side effects.

 

Dose escalation is not always necessary. If you have found a “sweet spot” where you are experiencing steady progress without significant negative side effects, remaining at that dose may be appropriate rather than continuing to increase.​

​

Our pens have an adjustable dosing of 0.25mg-2mg, with a shelf life of 12-18month.